REATA PHARMACEUTICALS INC Accrued Liabilities, Current
REATA PHARMACEUTICALS INC had Accrued Liabilities, Current of $25.14 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-08-08
- 2023-06-30: Accrued Liabilities, Current $25.14M.
- 2023-03-31: Accrued Liabilities, Current $19.45M.
- 2022-12-31: Accrued Liabilities, Current $13.84M.
- 2022-09-30: Accrued Liabilities, Current $18.03M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-06-30 | $25.14M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $19.45M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $13.84M 10-Q · filed 2023-08-08 | |
| 2022-09-30 | $18.03M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $14.23M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $14.93M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $14.25M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $17.55M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $15.70M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $12.62M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $14.02M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $17.99M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $16.69M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $19.91M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $23.77M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $19.85M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $20.87M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $16.26M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $15.42M 10-K · filed 2020-02-19 | |
| 2018-09-30 | $18.45M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $15.33M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $13.83M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $12.63M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $10.01M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $7.49M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $5.44M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $6.15M 10-K · filed 2018-03-02 | |
| 2016-09-30 | $4.42M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $4.21M 10-Q · filed 2016-08-11 | |
| 2015-12-31 | $3.98M 10-K · filed 2017-03-03 | $3.53M 10-Q · filed 2016-08-11 |